COMPASS Pathways
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
33 Broadwick St, London, Greater London,...Phone Number
+44 7166766461Website
www.compasspathways.comRevenue
$132 MillionStock Symbol
CMPSIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
3
4
1
2
2
2
About COMPASS Pathways
COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.Explore more
COMPASS Pathways Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is COMPASS Pathways your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once COMPASS Pathways has new funding data
Check if COMPASS Pathways has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when COMPASS Pathways launches new products
Click to see if COMPASS Pathways had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at COMPASS Pathways
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on COMPASS Pathways recently announced quarterly report
Check out if COMPASS Pathways is spiking on competitors!
COMPASS Pathways, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined COMPASS Pathways as Masked Content
Find 3 more new buyers
Compare Similar Companies to COMPASS Pathways
Compare insights from companies similar to COMPASS Pathways, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
COMPASS Pathways is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
COMPASS Pathways is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about COMPASS Pathways.
COMPASS Pathways financials insights
Gather financial insights about COMPASS Pathways, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$35.5M
2020
Series B
$80M
Stock Offering
$128M
2023
Debt
$50M
Other Financing Round
$285M
COMPASS Pathways Tech Stack
A closer look at the technologies used by COMPASS Pathways
See more technologies
Most Recent Scoops
Open Position
Open Position
Hiring Plans
COMPASS Pathways has more open roles in Legal than it has had at any time in the past 12 months. Areas of expertise include: Legislative Procedures, and Compliance Implementation.
Hiring Plans
Open Position
Project
Pharmaceuticals, Regulations
COMPASS Pathways News & Media
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United KingdomCOMPASS Pathways plc (CMPS) Q2 2026 Earnings Call Transcript
COMPASS Pathways plc (CMPS) Q2 2026 Earnings Call August 5, 2026 8:00 AM EDTCompany ParticipantsStephen Schultz - Senior Vice President of Investor...Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction ...
Post-hoc analysis of support methods used in an open-label Phase 2 COMP360 study showed monitoring and support provided during treatment administration sessions were minimal, non-directive and distinct from conventional conceptions of psychotherapy Findings published in the Journal of Psychopharmacology Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a post-hocIs COMPASS Pathways plc (CMPS) Stock a Psychedelic Medicine Opportunity After Positive COMP360 Data?
We recently compiled a list of the 7 Best Psychedelic Stocks to Buy According to Analysts. COMPASS Pathways plc (NASDAQ:CMPS) is one of the best psychedelic stocks on our list. TheFly reported on July 7 that Oppenheimer reaffirmed its Outperform rating and $20 price target on CMPS shares following new Phase 3 COMP006 26-week results. The firm […]
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding COMPASS Pathways
Sign Up For FreeTo access detailed company insights
COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psi... Read More
